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Abstract 
 6- Mercaptopurine (6-MP) is widely used in clinic as an immunosuppressive for treatment of acute lymphocytic 
leukemia, Crohn's disease, and ulcerative colitis with documented unpredictable hepatotoxicity. The potential 
molecular cytotoxic mechanisms of 6-MP against isolated rat hepatocytes were searched in this study using 
―Accelerated Cytotoxicity Mechanism Screening (ACMS)‖ techniques. The concentration of 6-MP required to cause 
50% cytotoxicity in 2 hour at 37∘C was detected to be 400 µM. A significant increase in 6-MP induced cytotoxicity 
and reactive oxygen species (ROS) formation, % mitochondrial membrane potential (MMP), lysosomal damage 
were observed. The addition of chloroquine (lysosomotropic agent), L-carnitine (inhibitor of membrane 
permeability transition (MPT), Diphenyleneiodonium (DPI) as an inhibitor of production of superoxide, and H2O2 
by mitochondria and Dimethyl sulfoxide (DMSO) as a radical scavenger decreased 6-MP-induced cytotoxicity, ROS 
formation, collapse of MMP, and lysosomal damage. Results from this study suggest that 6-MP -induced 
cytotoxicity in isolated rat hepatocytes due to ROS formation, mitochondrial and lysosomal damages that resulted in 
crosstalk toxicity between mitochondrial and lysosomal damage and finally cell death. 
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1. Introduction  
Drug-induced liver injury (DILI) is a main 
concern in clinical studies and also in post-
marketing surveillance of drugs [1]. Three 
thiopurine drugs have been commonly used in 
the last forty years such as 6-mercaptopurine (6-
MP), 6-thioguanine (6-TG) and azathioprine 
(AZA) are widely used for the treatment of 
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diseases such as autoimmune conditions, 
inflammatory bowel diseases (IBD), following 
transplantation to avoid organ rejection and 
acute leukemia [2]. In most of the cases, 
hepatotoxicity is an unforeseeable side effect of 
6-MP, whose pathogenic mechanism remains 
unknown [3]. Hepatotoxicity is a relatively 
unusual but important complication of 6-MP [4]. 
It is revealed by raising in aminotransferases and 
often accompanied by flu-like symptoms 
including headaches, nausea, and fatigue almost 
resolved after 6-MP discontinuation or dose 
reduction [5]. In some patients, however, a 
syndrome of liver vascular disorders or isolated 
cholestasis can be seen [6]. Measurement of the 
metabolite of 6-MP (6-MMPR) has been 
suggested as a means to recognized patients at 
risk for hepatotoxicity. Several studies have 
shown a positive relationship between the 
elevated metabolite of 6-MP levels and 
abnormal liver function tests in the pediatric 
population [7]. 
6-MP is a chose drug for treatment of 
inflammatory disorders. Moreover, previous 
studies suggests that some drugs during periods 
of inflammation can increase an individual’s 
susceptibility to toxicity [8].  Inflammation 
caused by endotoxins or infections markedly 
activates NADPH (nicotinamide adenine 
dinucleotide phosphate) oxidase that produces 
superoxide radicals by transferring electrons 
from NADPH. In the phagosome, superoxide 
radicals automatically generate form hydrogen 
peroxide (H2O2) and other reactive oxygen 
species (ROS) [9]. Finally drug toxicity has been 
cited as the most common reason for 
discontinuation of 6-MP therapy [10]. The aim 
of this study was study of toxic pathways 6-
mercaptopurine in rat hepatocytes using the 
―Accelerated Cytotoxicity Mechanism 
Screening‖ techniques. 
 
2. Materials and Methods  
2.1. Animals 
Male Sprague–Dawley rats weighing 250–
300 g were housed in a room at a stable 
temperature of 25
o
 C on a12/ 12 h light/dark 
cycle with water and food accessible ad libitum . 
All examinations were conducted according to 
ethical standards and protocols approved by the 
Committee of Animal Experimentation of 
Shahid Beheshti University of Medical Sciences, 
Tehran, Iran. 
 
2.2. Isolation of Hepatocytes 
Hepatocytes were received by collagenase 
perfusion of the liver. Viability of isolated 
hepatocytes was measured by trypan blue (0.2 
w/v) exclusion test. Hepatocytes were suspended 
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at a density of 10
6
 cells/mL in round-bottomed 
flasks rotating in a water bath maintained at 37º 
C in Krebs-Henseleit buffer (pH = 7.4), 
supplemented with 12.5 mM HEPES under an 
atmosphere of 10% O2, 85% N2, and 5% CO2. 
Aliquots of the hepatocyte incubate were taken 
at different time points during the 3 h incubation 
period. At least 80–90% of the control cells were 
still viable after 2 h [11]. 
 
2.3. Viability Assessment  
Hepatocyte viability was tested 
microscopically by plasma membrane 
disruption, as determined by the trypan blue 
(0.2% w/v) exclusion test. Hepatocyte viability 
was assessed every 30 min during the 3 h 
incubation period, and the hepatocytes were at 
least 80–90% viable before use. To avoid either 
non-toxic or severe toxic conditions in this 
study, EC50 2h concentrations were used for 6-
MP. The EC502h of a chemical in hepatocyte 
cytotoxicity assessment technique is defined as 
the concentration, which decreased the 
hepatocyte viability to 50% following the 2 h 
incubation period [11]. 
 
2.4. ROS Assay 
Hepatocyte reactive oxygen species (ROS) 
formation induced by the 6-MP was detected by 
adding dichlorofluorescin diacetate (DCFD). 
DCFD interpenetrates to hepatocytes and is 
hydrolyzed to non- fluorescent 
dichlorofluorescin. Dichlorofluorescin is then 
oxidized by ROS to form the highly fluorescent 
dichlorofluorescein which effluxes the cell. 
After incubation with 6-MP, 1000 µL samples of 
cells were withdrawn at 30 and 60 min and 
centrifuged at 50 rpm for 1 min. The cells were 
suspended in Krebs–Henseleit buffer and 1.6 
µM DCFD was added. Hepatocytes were 
allowed to incubate at 37°C for 10 min. 
Excitation and emission wavelengths were 490 
and 520 nm, respectively[11]. 
 
2.5. MMP Assay 
The uptake and retention of the cationic 
fluorescent dye, rhodamine 123, has been used 
for the assessment of MMP collapse. This 
measurement is based on the fact that 
rhodamine 123 accumulates selectively in the 
mitochondria by facilitated diffusion. However, 
when the mitochondrial potential is decreased, 
the amount of rhodamine 123 that enters the 
mitochondria is also decreased as there is no 
facilitated diffusion. Thus, the amount of 
rhodamine 123 in the supernatant is increased 
and the amount in the pellet is decreased. 
Samples (0.5 ml) were taken from the cell 
suspension incubated at 37 °C at different time 
points, and centrifuged at 50 × g for 1 min. The 
cell pellet was then resuspended in 2 mL of 
fresh incubation medium containing 1.5 µM 
rhodamine 123 and incubated at 37 °C in a 
thermostatic bath for 10 mins with gentle 
shaking. Cells were separated by centrifugation 
and the amount of rhodamine 123 appearing in 
Salimi A, et al / IJPS 2016; 12 (3): 65-74 
 
 
68 
 
the incubation medium was measured 
fluorimetrically, using Hitachi F-2500 
fluorescence spectrophotometer set at 490 nm 
excitation and 520 nm emission wavelengths. 
The capacity of mitochondria to take up the 
rhodamine 123 was calculated as the difference 
in fluorescence intensity between control and 
treated cells [11]. 
 
2.6. Lysosomal Membrane Integrity Assay 
Hepatocyte lysosomal membrane stability 
was measured from the redistribution of the 
fluorescent probe, acridine orange. Aliquots of 
the hepatocytes suspension (0.5 mL) that were 
previously incubated with acridine orange (5 
μM) were separated from the incubation 
medium by 1 min centrifugation at 1000 rpm. 
The hepatocyte pellet was then resuspended in 2 
mL of incubation medium. This washing 
process was repeated for two times to remove 
the fluorescent dye. Acridine orange 
redistribution in the hepatocytes suspension was 
then measured fluorimetrically Hitachi F-2500 
fluorescence spectrophotometer set at excitation 
and emission wavelengths 490 and 520 nm, 
respectively [11]. 
 
2.7. Statistical Analysis 
Results are presented as means ± SD. All 
statistical analyses were performed using Graph 
Pad Prism (version 5, Graph pad Software Inc.). 
Assays were performed in triplicate and the 
mean was used for the statistical analysis. 
Statistical significance was determined using 
the one-way ANOVA test, followed by the 
post-hoc Tukey test. In some experiments, the 
two-way ANOVA test, followed by the post-
hoc Bonferroni test was also performed. 
Statistical significance was set at P < 0.05. 
 
3. Results and Discussion 
3. 1. Results 
3.1.1. Cytotoxicity  
The EC50, 2h concentration found for 6-Mp 
was equivalent to 200 µM and. As shown in 
figure 1, 6-MP significantly decreased 
hepatocyte viability compared to control 
hepatocytes (P < 0.05). 6-MP induced 
cytotoxicity was significantly (P < 0.05) 
prevented by chloroquine, L-carnitine, DPI, and 
DMSO.  
 
3.1.2. ROS Formation  
Incubation of hepatocytes with 6-MP (200, 
400 and 800 µM) caused a significant increase 
in ROS formation as compared with control 
hepatocytes (P < 0.05) (Table 1). Pretreatment 
of hepatocytes by different agents such as 
chloroquine, L-carnitine, DPI and DMSO 
showed protection against 6-MP induced ROS 
formation in a time-dependent manner (Table 
1).  
 
 
Salimi A, et al / IJPS 2016; 12 (3): 65-74 
 
 
69 
 
3.1.3. MMP Collpase 
As shown in table 2, 6-MP (200, 400 and 800 
µM) also caused a rapid decline of 
mitochondrial membrane potential as compared 
with control hepatocytes (P < 0.05) which was 
pre-vented by different agent such as 
chloroquine, L-carnitine, DPI, and DMSO.  
 
3.1.4. Lysosomal Damage  
When hepatocyte lysosomes were loaded 
with acridine orange (a lysosomotropic agent), a 
significant redistribution of acridine orange into 
the cytosolic fraction ensued within 30 and 60 
min of incubation with 6-MP. 6-MP induced 
acridine orange release were again prevented by 
chloroquine, L-carnitine, DPI, and DMSO 
indicating sever oxidative damage to lysosomal 
membrane (Table 3).   
 
3.2. Discussion 
Drug hepatoxicity can be nonidiosyncratic 
(predictable) or idiosyncratic (unpredictable). 
 
Figure 1. Effect of ROS scavengers, MPT pore sealing agents, lysosomotropic agents, and NADPH P450 
reductase inhibitor on 6-MP-induced hepatocyte toxicity. Hepatocytes (10
6
 Cells/mL) were incubated in Krebs–
Henseleit buffer with pH of 7.4 at 37° C for 1.0 h following the addition of 6-MP. Cytotoxicity was determined as 
the percentage of cells that uptake trypan blue. Values are expressed as mean ± SD of three separate experiments 
(n = 3).  
***: Significant difference in comparison with control hepatocytes (p  < 0.05);  
$$$ : Significant difference in comparison with 6-MP treated hepatocytes (p  < 0.05) 
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New epidemiologic data suggest that 
approximately 20 new cases of DILI per 
100,000 persons occur each year. Idiosyncratic 
DILI accounts for 11% of the cases of acute 
liver failure [3]. Previous evidence suggests that 
drug exposure during periods of inflammation 
can increase an individual's susceptibility to 
toxicity [12]. Mercaptopurine, one of drugs that 
used form inflammatory disorder is believed to 
have a direct, similar types of injury and dose 
related hepatotoxic effect can be reproduced in 
animal studies [13, 14]. The hepatotoxic effects 
of mercaptopurine, have been linked to higher 
levels of methyl-mercaptopurine, a metabolite of 
mercaptopurine that is produced during 
metabolism. Also the acute cholestatic hepatitis 
associated with mercaptopurine, is more likely 
due to idiosyncratic reaction [15]. 
Previous studies have demonstrated that 
azathioprine a parent compound of 6-MP 
decreased the viability of rat hepatocytes [16]. 
Our study shows the mechanism by which 
clinically relevant concentrations of 6-MP (200-
800 µM) damage rat isolated hepatocytes. In 
primary studies, 200, 400, and 800 µM 
concentrations of  6-MP were toxic, and 6-MP 
profoundly decreased cell viability; further, 
cytotoxicity was prevented  by lysosomotropic 
agent (Chloroquine), MPT pore sealing agents 
(Carnitine), NADPH P450 reductase inhibitor  
(DPI) and hydroxyl radical  scavenger (dimethyl 
sulfoxide) (Figure 1). All of these reagents did 
not show any effects on hepatocyte toxicity at 
concentrations used (data not shown). 
Our findings regarding oxidative stress 
parameters revealed that 6-MP could increase 
Table 1. Effect of ROS scavengers, MPT pore sealing agents, lysosomotropic agents, and NADPH P450 
reductase inhibitor on 6-MP-induced hepatocyte toxicity, ROS formation.  
Addition   
ROS 
200 µM 400 µM 800 µM 
30 min 60 min 30 min 60 min 30 min 60 min 
Control 152 ± 11.4 154 ± 9.4 430 ± 13.3 454 ± 12 468 ± 9.4 526 ± 10.4 
6-MP 152 ± 12.2 160 ± 8.7
a 
583 ± 14.1
a 
592 ± 11.7
a 
669 ± 13.1
a 
716 ± 12.4
a 
+Chloroquine (100 
µM) 
125 ± 6.4
b 
150 ± 3.5
b 
431 ± 10
b 
461 ± 9.5
b 
576 ± 11.5
b 
706 ± 6.4 
+Carnitine (2 mM) 125 ± 6.1
b 
127 ± 2.8
b 
527 ± 9.4
b 
570 ± 11.3
b 
496 ± 10.6
b 
532 ± 8.4
b 
+DPI(50 µM) 145 ± 7.1
b 
143 ± 6.4
b 
448 ± 8,6
b
  538 ± 10.3
b 
551 ± 9.2
b 
574 ± 9.7
b 
+DMSO (150 µM) 145 ± 4.2
b 
143 ± 5.4
b 
441 ± 11.2
b 
458 ± 12
b 
572 ± 11.4
b 
706 ± 9.4 
Hepatocytes (106 Cells/mL) were incubated in Krebs–Henseleit buffer with pH of 7.4 at 37° C for 1.0 h following the addition 
of 6-MP. Cytotoxicity was determined as the percentage of cells that uptake trypan blue. DCF formation was expressed as 
fluorescent intensity units. Values are expressed as mean ± SD of three separate experiments (n = 3).  
a : Significant difference in comparison with control hepatocytes (p  < 0.05);  
b : Significant difference in comparison with 6-MP treated hepatocytes (p  < 0.05). 
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ROS production. The increased ROS formation 
may play a significant role in the enhancement 
of lipid peroxidation and finally cellular and sub 
cellular mem-brane damage. Pervious 
investigation revealed that clinically relevant 
concentrations of 6-MP and azathioprine are 
toxic to rat hepatocyte cultures by a mechanism 
that involves oxidative stress, mitochondrial 
injury, and ATP depletion [17]. 
Mitochondria are involved in the generation 
of ROS through one-electron carriers in the 
respiratory chain; mitochondrial structures are 
also very susceptible to oxidative stress [18]. 
Our results proved that 6-MP could cause 
mitochondrial damage which could be prevented 
by lysosomotropic agent (Chloroquine), MPT 
pore sealing agents (Carnitine), NADPH P450 
reductase inhibitor  (DPI), and hydroxyl radical  
scavenger (dimethyl sulfoxide)  (Table 2). Also 
mitochondria damages may lead to release of 
proapoptotic agents from mitochondria to 
cytosol and finally induce apoptosis through 
mitochondria pathways [19] related to oxidative 
stress induced by 6-MP. Previous study showed 
that azathioprine a parent compound of 6-MP 
involves depletion of GSH leading to 
mitochondrial injury with profound depletion of 
ATP and cell death that was prevented by potent 
antioxidants, glycine and blocking the 
mitochondrial permeability transition pore [16]. 
 
Table 2. Effect of 6-MP, ROS scavengers, MPT pore sealing agents, lysosomotropic agents, and NADPH P450 
reductase inhibitor on 6-MP-induced mitochondrial injury in hepatocytes  
Addition   
MMP collapse  
200 µM 400 µM 800 µM 
30 min 60 min 30 min 60 min 30 min 60 min 
Control 2329 ± 21.5 2480 ± 27.8 2390 ± 23.6 2593 ± 32.2 2382 ± 
27.8 
2450 ± 
40.6 
6-MP 3117  ± 
24.2
a 
3493 ± 21.7
a 
3631 ± 24.8
a 
3973 ± 36.6
a 
5080 ± 
33.1
a 
5693 ± 
32.8
a 
+Chloroquine (100 
µM) 
2435 ± 18.4
b 
2632 ± 19.1
b 
2737 ± 26.9
b 
2874 ± 24.8
b 
3245 ± 
37.5
b 
3833 ± 
29.4
b 
+Carnitine (2 mM) 2423 ± 16.1
b 
2641 ± 23.8
b 
2768 ± 29.3
b 
2643 ± 17.8
b 
3304 ± 
20.6
b 
3754 ± 
28.7
b 
+DPI(50 µM) 2440 ± 19.3
b 
2664 ± 27.3
b 
2775±32.6
b
  2947 ± 30.4
b 
3137 ± 
27.5
b 
3932 ± 
29.4
b 
+DMSO (150 µM) 2408 ± 23.1
b 
2601 ± 31.2
b 
2530 ± 33.6
b 
2643 ± 37
b 
3002 ± 
34.4
b 
3635 ± 
41.4
b 
Hepatocytes (106 Cells/mL) were incubated in Krebs–Henseleit buffer with pH of 7.4 at 37° C for 1.0 h following the 
addition of 6-MP. Cytotoxicity was determined as the percentage of cells that uptake trypan blue. MMP collapse was 
expressed as fluorescent intensity units. Values are expressed as mean ± SD of three separate experiments (n = 3).  
a: Significant difference in comparison with control hepatocytes (p  < 0.05);  
b : Significant difference in comparison with 6-MP treated hepatocytes (p  < 0.05). 
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When hepatocyte were loaded with acridine 
orange ensued within 30 and 60 min the loaded 
hepatocytes were treated with 6-MP, indicating 
leakiness of the lysosomal membrane (Table 3). 
On the other hand, the 6-MP-induced acridine 
orange release was prevented by the 
lysosomotropic agent (chloroquine), MPT pore 
sealing agents (carnitine), NADPH P450 
reductase inhibitor  (DPI), and hydroxyl radical  
scavenger (dimethyl sulfoxide), suggesting 
involvement of pH- dependent intralysosomal 
Fenton’s type reactions and ROS formation in 6-
MP-induced lysosomal membrane damage in 
hepatocyte [20]. 
 
4. Conclusion 
All our results were in favor of the 
entanglement of the ROS formation hypothesis 
in 6MP-induced hepatocyte cytotoxicity, since 
both lysosomal membrane labilization and the 
decline in MMP were attended following the 6-
MP-induced ROS formation and cytotoxicity in 
hepatocytes. It is supposed that the ROS 
formation causes damage on lysosomal and 
mitochondrial membranes through lipid 
peroxidation, which finally leads to cell death 
[21]. 
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